Search for resources
Tea with ASTP: Negotiating Licensing Terms
In this webinar recording, Anja Zimmerman, discusses how knowledge and technology transfer can happen in numerous ways, from publication of research results to collaborations between scientist, between research organisations, between academia and industry or by creating companies.
Valorisation of scientific results Patent commercialisation scoreboard: European universities and PROs”, finds that licensing is by far the preferred channel of commercialisation (accounting for 70% of the commercialisation of inventions), followed by R&D co-operation (14%) and the sale of patents (9%).
Tea with ASTP: Technology Marketing
Sometimes universities and research organisations fail to turn research results into marketable products or services, not because of lack of scientific excellence or technical innovativeness but, because of non-technological barriers such as economic, environmental, social, regulatory, or legal obstacles.
Tea with ASTP: Knowledge Transfer for a Data Economy
The ever-increasing digital transformation of our society and economy is bringing along the generation of a wealth of data with high value-add potential through the extraction of useful insights.
Tea with ASTP: Frugal Innovations
Frugal Innovation is the art of developing solutions by “doing more with less" creating more aggregate value for a client while reducing energy, waste, complexity, time and capital of a product. Hear Allan Báez Morales, Director of Programs and Partnerships at the Frugal Innovation Hub, University of Santa Clara, Ca.
Tea with ASTP: Managing and valorising clinical data
Large healthcare datasets, Artificial Intelligence and Machine Learning can change the clinical innovation landscape. However, data access and valorisation cannot discount patients' rights; dealing with clinical data often represents a challenge for the collaboration between universities and research hospitals.
Tea with ASTP: IP management strategies at the time of covid-19
The pandemic prompted universities and public research organisations to re-think their IP management strategies. Various open licenses have been developed granting free temporary access to IP rights to tackle the coronavirus crisis. Do IPRs represent a barrier to access innovation in times of health emergencies?